MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-311

  1. 17,010 Posts.
    lightbulb Created with Sketch. 2412
    Whats this mean??
    "increased composite outcomes of reduction in pain together with improvement in function in those with CLBP of shorter duration than 68 months, the median for the study; however, the composite outcomes of pain and function did not reach statistical significance across the entire study"

    No it's not "normal"

    It's SI's very slight nod to the fact that the composite outcomes was the primary endpoint of the trial...
    Last edited by whytee: 11/02/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.